Lee Anne Siegmund, PhD, RN, CEP Nurse Scientist, Office of Nursing Research and Innovation, Cleveland Clinic, Cleveland, Ohio. Nancy M. Albert, PhD, RN, CCNS, CHFN, NE-BC, FAHA, FAAN Associate Chief Nursing Officer, Office of Nursing Research and Innovation, Cleveland Clinic, Cleveland, Ohio. Mark S. McClelland, DNP, RN, CPHQ Director of Quality, International Operations, Cleveland Clinic, Cleveland, Ohio. James F. Bena, MS Lead Biostatistician, Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio. Shannon L. Morrison, MS Program Analyst, Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
J Cardiovasc Nurs. 2018 Jul/Aug;33(4):306-312. doi: 10.1097/JCN.0000000000000454.
Phase II cardiac rehabilitation reduces hospital readmissions and cardiovascular disease risk factors and improves functional capacity. Cardiovascular disease risk factors double with patients with metabolic syndrome, a population less likely to adhere to cardiac rehabilitation.
The aim of this study was to determine relationships between cardiac rehabilitation uptake timing, demographic variables and functional capacity, and readmission in patients with metabolic syndrome.
This retrospective, medical records study involved 353 patients with metabolic syndrome who subsequently received cardiac rehabilitation. Logistic regression was used to examine relationships between time from discharge to cardiac rehabilitation uptake and readmission. Unordered categorical factors were compared between readmission groups using Pearson χ tests. Multivariable logistic regression was used to identify predictors of readmission.
Patients readmitted within 30 and 90 days of hospitalization were more often women (P ≤ .018) and nonwhite (P ≤ .002) and had lower functional capacity (P < .001). In multivariable analysis, white race (odds ratio [OR], 0.50 [95% confidence interval (CI), 0.25-0.99]; P = .045) and higher functional capacity (OR, 0.80 [95% CI, 0.68-0.93]; P = .005) were protective against hospital readmission within the first 90 days. Race, sex, and functional capacity remained significant predictors of readmission at 1 year. In multivariable analysis, only race (OR, 0.41 [95% CI, 0.22-0.79]; P = .007) and functional capacity (OR, 0.83 [95% CI, 0.73-0.95]; P = .007) were significant. Early cardiac rehabilitation was not associated with readmission at any time point (P > .05).
Sex, race, and functional capacity were important predictors of readmission for metabolic syndrome, even when cardiac rehabilitation intake was delayed. Results raise questions about the unique traits of patients with metabolic syndrome and need for novel approaches to improve cardiac rehabilitation utilization and functional capacity in metabolic syndrome.
二期心脏康复可降低医院再入院率和心血管疾病风险因素,并改善功能能力。患有代谢综合征的患者,心血管疾病风险因素增加一倍,而他们更不可能坚持心脏康复治疗。
本研究旨在确定代谢综合征患者心脏康复治疗开始时间、人口统计学变量与功能能力和再入院之间的关系。
这是一项回顾性病历研究,共纳入 353 例代谢综合征患者,随后接受了心脏康复治疗。采用逻辑回归分析评估从出院到接受心脏康复治疗的时间与再入院之间的关系。采用 Pearson χ 检验比较再入院组之间无序分类因素的差异。采用多变量逻辑回归分析确定再入院的预测因素。
在住院后 30 天和 90 天内再入院的患者更常见为女性(P ≤.018)和非白人(P ≤.002),且功能能力较低(P <.001)。多变量分析显示,白人种族(比值比[OR],0.50[95%置信区间(CI),0.25-0.99];P =.045)和较高的功能能力(OR,0.80[95%CI,0.68-0.93];P =.005)是前 90 天内医院再入院的保护因素。种族、性别和功能能力仍然是 1 年内再入院的显著预测因素。多变量分析显示,只有种族(OR,0.41[95%CI,0.22-0.79];P =.007)和功能能力(OR,0.83[95%CI,0.73-0.95];P =.007)是显著的预测因素。心脏康复治疗开始时间早与任何时间点的再入院无关(P >.05)。
即使心脏康复治疗开始时间延迟,性别、种族和功能能力仍是代谢综合征患者再入院的重要预测因素。研究结果提出了有关代谢综合征患者独特特征的问题,需要采用新方法来提高代谢综合征患者的心脏康复治疗利用率和功能能力。